HIV infection was associated with significant weight loss before the advent of potent antiretroviral therapy (ART). Weight gain while on treatment was seen as a clinical indicator of treatment success. Perceptions of health care providers (HCPs) about obesity among people living with (PLHIV) were examined. We conducted 16 key informant interviews with HCPs in two states in southeastern Nigeria, which were then coded thematically. The respondents included seven physicians, four nurses, three adherence counselors, and two pharmacists. The analysis revealed three key themes: HCPs do not see excess weight gain as a problem; there are several challenges in managing obesity among PLHIV; and comorbidities play a role in the management of obesity among PLHIV. We conclude that obesity among PLHIV is an important clinical issue that HCPs need to address with the commencement of ART.

在有效的抗逆转录病毒疗法 (ART) 出现之前，HIV 感染与显着的体重减轻有关。治疗期间体重增加被视为治疗成功的临床指标。调查了医疗保健提供者 (HCP) 对感染者 (PLHIV) 肥胖的看法。我们对尼日利亚东南部两个州的 HCP 进行了 16 次关键线人访谈，然后按主题进行了编码。受访者包括七名医生、四名护士、三名依从性顾问和两名药剂师。分析揭示了三个关键主题： HCP 不认为体重增加过多是一个问题；在 PLHIV 中管理肥胖有几个挑战；和合并症在 PLHIV 中的肥胖管理中发挥作用。